[{"AccountsPayableCurrent_0_Q1_USD":15321000.0,"LongTermInvestments_0_Q1_USD":486036000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":5459000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":13982000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":8850000.0,"ContractWithCustomerAssetNetCurrent_0_Q1_USD":0.0,"ShortTermInvestments_0_Q1_USD":597028000.0,"PaymentsToAcquireInvestments_1_Q1_USD":251505000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":358976000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":641070000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":470651000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":10451000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":8.27,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-3291000.0,"EarningsPerShareDiluted_1_Q1_USD":0.15,"DepreciationDepletionAndAmortization_1_Q1_USD":2175000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":10128000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":163187000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":60035000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-3291000.0,"InterestIncomeOther_1_Q1_USD":7220000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":45321000.0,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":31831000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q1_USD":-941000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":65100000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":26687000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":13982000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":226915000.0,"RestrictedCashEquivalentsNoncurrent_0_Q1_USD":1636000.0,"ReceivablesNetCurrent_0_Q1_USD":137338000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":287086000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":3938000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1793000.0,"OtherNoncashIncomeExpense_1_Q1_USD":888000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":47883000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_investment":144.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":3448000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":351135000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"CustomerRefundLiabilityCurrent_0_Q1_USD":23006000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":18800000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":1600000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":14133000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1300000.0,"ContractWithCustomerLiability_0_Q1_USD":15400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":90839000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":1111721000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":1111837000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":3448000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":3332000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":305388000.0,"ValuationAllowancesAndReservesBalance_0_Q1_USD":35663000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":2379000.0,"OtherAssetsNoncurrent_0_Q1_USD":57312000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":48489000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":29773000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":2961000.0,"NetIncomeLoss_1_Q1_USD":48612000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":56074000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":32620000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2145000.0,"LiabilitiesCurrent_0_Q1_USD":140477000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1955604000.0,"Liabilities_0_Q1_USD":207952000.0,"InventoryNet_0_Q1_USD":15417000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-510739000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":2863000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-2131000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":11423000.0,"CostsAndExpenses_1_Q1_USD":174106000.0,"CommonStockValue_0_Q1_USD":306000.0,"CommonStockSharesOutstanding_0_Q1_shares":305780000.0,"CommonStockSharesIssued_0_Q1_shares":305780000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":357340000.0,"AssetsCurrent_0_Q1_USD":1136896000.0,"Assets_0_Q1_USD":1955604000.0,"AdditionalPaidInCapital_0_Q1_USD":2258307000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-222000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":18270000.0,"Revenues_1_Q1_USD":226915000.0,"StockholdersEquity_0_Q1_USD":1747652000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"Goodwill_0_Q1_USD":63684000.0,"EarningsPerShareBasic_1_Q1_USD":0.16,"CostOfGoodsAndServicesSold_1_Q1_USD":9289000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":481000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":18.84,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":19750438.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":6000.0,"InterestReceivable_0_Q1_USD":5400000.0,"InventoryWorkInProcess_0_Q1_USD":14278000.0,"InventoryRawMaterials_0_Q1_USD":2215000.0,"InventoryGross_0_Q1_USD":21358000.0,"InventoryFinishedGoods_0_Q1_USD":4865000.0,"IncreaseDecreaseInInventories_1_Q1_USD":4695000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.19,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":315839000.0,"ShareBasedCompensation_1_Q1_USD":13982000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":62940000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":101877000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":52809000.0,"CommonStockSharesAuthorized_0_Q1_shares":400000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":271370.0,"ValuationAllowancesAndReservesDeductions_1_Q1_USD":49256000.0,"Ticker":"EXEL","CIK":"939767","name":"EXELIXIS, INC.","OfficialName":"Exelixis Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7287350058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200505"}]